Detalhe da pesquisa
1.
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.
Clin Microbiol Rev
; 35(3): e0022721, 2022 09 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35311552
2.
A systematic review of potential biomarkers for bacterial burden and treatment efficacy assessment in TB platform-based clinical trials.
J Infect Dis
; 2023 Nov 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37956107
3.
Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse.
Clin Infect Dis
; 76(3): e990-e994, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35717643
4.
Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania.
BMC Genomics
; 23(1): 561, 2022 Aug 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35931954
5.
The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
Trop Med Int Health
; 27(10): 891-901, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36089572
6.
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
N Engl J Med
; 388(24): 2297, 2023 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37314715
7.
Optimising pyrazinamide for the treatment of tuberculosis.
Eur Respir J
; 58(1)2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33542052
8.
Increased bactericidal activity but dose-limiting intolerability at 50â mg·kg-1 rifampicin.
Eur Respir J
; 58(1)2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33542056
9.
Molecular epidemiology of respiratory syncytial virus in children in sub-Saharan Africa.
Trop Med Int Health
; 26(7): 810-822, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33683751
10.
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay.
Thorax
; 75(7): 606-608, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32354738
11.
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.
Clin Infect Dis
; 67(1): 34-41, 2018 06 18.
Artigo
Inglês
| MEDLINE | ID: mdl-29917079
12.
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP).
BMC Med
; 14: 51, 2016 Mar 23.
Artigo
Inglês
| MEDLINE | ID: mdl-27004726
13.
Drug resistance and population structure of M.tuberculosis isolates from prisons and communities in Ethiopia.
BMC Infect Dis
; 16(1): 687, 2016 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-27871250
14.
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Am J Respir Crit Care Med
; 191(9): 1058-65, 2015 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25654354
15.
Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania.
Eur Respir J
; 46(3): 761-70, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26113682
16.
The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations.
J Antimicrob Chemother
; 70(2): 448-55, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25344806
17.
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients.
J Antimicrob Chemother
; 70(5): 1558-66, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25630641
18.
The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment.
J Clin Microbiol
; 52(8): 3064-7, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24871215
19.
Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles.
Lancet Microbe
; 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38735303
20.
Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countries.
Lancet Infect Dis
; 24(2): 140-149, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37918414